1. home
  2. > health & wellness
  3. > Plasma from recovered shows little benefit in Covid patients: study
replay trump newslist
up NEXT IN 5 SECONDS sports newslist
tap to unmute
00:00/00:00
NaN/0

Plasma from recovered shows little benefit in Covid patients: study

Nov 29, 2020 14:29 IST

Using blood plasma from Covid-19 survivors to treat patients with severe pneumonia caused by the novel coronavirus showed little benefit, according to data released on Tuesday from a clinical trial in Argentina. The therapy known as convalescent plasma, which delivers antibodies from Covid-19 survivors to infected people, did not significantly improve patients' health status or reduce their risk of dying from the disease any better than a placebo, the study published in The New England Journal of Medicine found. Despite limited evidence of its efficacy, US President Donald Trump touted convalescent plasma, as a "historic breakthrough," in August. In October, a small study from India suggested convalescent plasma improved symptoms in COVID-19 patients, such as shortness of breath and fatigue, but did not reduce the risk of death or progression to severe disease after 28 days.

Health & Wellness